Heribert Staudinger - Researcher Profile

Publications

3 shown

Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials

Claus Bachert , Joseph K. Han , Martin Desrosiers +31 more

2019 The Lancet 1335 citations

Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma

Klaus F. Rabe , Parameswaran Nair , Guy Brusselle +18 more

In patients with glucocorticoid-dependent severe asthma, dupilumab treatment reduced oral glucocorticoid use while decreasing the rate of severe exacerbations and increasing the...

2018 New England Journal of Medicine 1086 citations

Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma

Mario Castro , Jonathan Corren , Ian Pavord +24 more

In this trial, patients who received dupilumab had significantly lower rates of severe asthma exacerbation than those who received placebo, as well as better lung function and a...

2018 New England Journal of Medicine 1777 citations

Frequent Co-Authors

Researcher Info

h-index: 3
Publications: 3
Citations: 4,198
Institution: National Institute for Health Research

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0001-5670-8591

Impact Metrics

h-index 3

h-index: Number of publications with at least h citations each.